Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Filings indexed 568 across all filing types
Latest filing 2023-06-15 Transaction in Own Shar…
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
回购股份注销完成暨股份变动公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the completion of a share repurchase and cancellation, including details about the number of shares repurchased, the adjustment of share prices due to dividends, and changes in the company's shareholding structure. It also mentions the company's plans to handle subsequent registration changes and includes a confirmation certificate from the securities registration company. There are no financial statements or detailed financial performance data, nor is this a report or presentation. The content clearly fits the category of a Transaction in Own Shares (POS), which covers share buybacks and cancellations.
2023-06-15 Chinese
广东东方昆仑(东莞)律师事务所关于惠州市锦好医疗科技股份有限公司2023年第一次临时股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, qualifications of attendees, and voting results of the 2023 first extraordinary general meeting (临时股东大会) of Huizhou Jin Hao Medical Technology Co., Ltd. It details the legality and compliance of the meeting process and the validity of the resolutions passed. The document does not contain financial statements or financial performance data, nor is it a report of financial results or management discussion. It is a legal opinion related to a shareholders' meeting and the voting process. This type of document is best classified as Declaration of Voting Results & Voting Rights Announcements (DVA), since it reports on the voting results and legality of the shareholder meeting resolutions.
2023-06-11 Chinese
2023年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the company's first extraordinary general meeting of shareholders in 2023. It details the meeting date, attendance, agenda items, voting results, and legal opinions on the meeting's validity. The content focuses on shareholder meeting decisions, including share repurchase and capital reduction proposals, with voting outcomes. There are no financial statements or detailed financial performance data presented. The document is a formal announcement of shareholder meeting resolutions and voting results rather than a full report or presentation. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2127 characters), consistent with a voting results announcement rather than a full report.
2023-06-11 Chinese
公司章程
Governance Information Classification · 95% confidence The document is a detailed company charter (章程) for Huizhou JingHao Medical Technology Co., Ltd., dated June 2023. It includes comprehensive sections on company organization, shareholder rights, board structure, share issuance, share transfer restrictions, shareholder meetings, and governance rules. The content is legal and governance-related, focusing on the company's internal rules, shareholder meetings, board responsibilities, and related procedures. There is no indication of financial statements, audit opinions, earnings data, or capital market transactions. The document is not a report of financial results or an announcement but a formal governance document outlining the company's articles of association. Therefore, the most appropriate classification is Governance Information (CGR).
2023-06-11 Chinese
关于拟减少注册资本通知债权人公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Huizhou Jin Hao Medical Technology Co., Ltd. regarding a proposed reduction in registered capital due to the repurchase and cancellation of restricted shares related to an equity incentive plan. It includes details about the board and shareholder approvals, legal references, and instructions for creditors to submit claims within a specified period. The document is a formal notification to creditors about the capital reduction and related procedures, not a financial report or detailed management discussion. It does not contain financial statements or detailed financial analysis but serves as a regulatory announcement to inform stakeholders of corporate actions and legal compliance. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-06-11 Chinese
实际控制人之一致行动人减持股份计划公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding a shareholder's plan to reduce their shareholding in the company. It details the shareholder's identity, the number and percentage of shares to be reduced, the method and timing of the reduction, and compliance with relevant regulations. There is no financial data, earnings information, or report attached or referenced as being published. The document is a formal disclosure of a shareholding reduction plan by a significant shareholder, which fits the category of Transaction in Own Shares (POS). The document length is short and focused solely on the share reduction plan, confirming it is not a full financial report or other type of filing.
2023-06-06 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.